Assembly Biosciences (ASMB) Revenue Growth (3y) (2020 - 2024)

Assembly Biosciences (ASMB) Revenue Growth (3y) (2020 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 50.07%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 7.94%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 4.47%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 81.24%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Assembly Biosciences 431.63 Mn 205.03 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 3.06%
Dec 31, 2023 90.45%
Sep 30, 2021 13.42%
Dec 31, 2020 -32.12%
Sep 30, 2020 135.20%
Jun 30, 2020 155.56%
Mar 31, 2020 81.37%